EXHIBIT10.24(b)AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT          THIS AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and betweenMylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and                      (the“Executive”), is made as of March 31, 2006.          WHEREAS, the Company and the Executive are parties to that certain Transition and SuccessionAgreement dated as of                      (the “Agreement”);          WHEREAS, the Company and the Executive wish to amend the Agreement, as set forth below;          NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which arehereby acknowledged, the parties hereto, intending to be legally bound, agree as follows: 1. Section 1(a) of the Agreement is hereby amended to add the following sentence at theend of such subsection:“For the sake of clarity, it is understood that if the Executive’s employment terminates priorto the Effective Date other than as described in the preceding sentence, this Agreement shallthereupon be null and void and of no further force and effect.” 2. The reference to “65%” in Section 1(d)(3) of the Agreement is hereby deleted andreplaced with “50%”.  3. The introductory clause of Section 5(a)(1) of the Agreement is hereby deleted andreplaced in its entirety to read as follows:“(1) the Company shall pay to the Executive (or the Executive’s estate or beneficiary, in theevent of the Executive’s death), in a lump sum in cash within 30 days after the Date ofTermination (or, if required by Section 409A of the Code to avoid the imposition of additionaltaxes, on the date that is six (6) months following the Date of Termination), the aggregate ofthe following amounts:” 4. Section 5(a)(1)(B) of the Agreement is hereby deleted and replaced in its entirety toread as follows:“the amount equal to the product of (i) three and (ii) the amount of base salary and cash bonuspaid to the Executive by the Company as reflected on the Executive’s W-2 in the tax yearimmediately preceding the year in which the Date of Termination occurs or the Change of Controloccurs, whichever is greater (in the case of death or resignation for Good Reason by reason ofthe Executive’s Disability, reduced (but not below zero) by any death or disability benefitsthat the Executive or the Executive’s
 

 
estate or beneficiaries are entitled to pursuant to plans or arrangements of the Company),provided that if the Executive was not employed by the Company during such entire tax year,item (ii) shall refer to the amount of base salary and cash bonus as agreed to in Executive’soffer of employment letter;” 5. The first sentence of Section 5(a)(2) of the Agreement is hereby deleted and replacedin its entirety to read as follows:“for three years after the Executive’s Date of termination (or such shorter period as requiredby Section 409A of the Code to avoid the imposition of additional taxes), the Company shallcontinue benefits to the Executive and/or the Executive’s dependents at least equal to thosethat were provided to them (taking into account any required employee contributions,co-payments and similar costs imposed on the Executive and the Executive’s dependents and taxtreatment of participation in plans, programs, practices and policies by the Executive and theExecutive’s dependents) in accordance with the plans, programs, practices, and policiesdescribed in Section 3(b)(4) as of the Date of Termination or, if more favorable to theExecutive, as in effect generally at any time thereafter with respect to other peer executivesof the Company and the Affiliated Companies and their dependents; provided, however, that, ifthe Executive becomes reemployed with another employer and is eligible to receive such benefitsunder another employer provided plan, the medical and other welfare benefits described hereinshall be secondary to those provided under such other plan during such applicable period ofeligibility.” 6. Section 11 of the Agreement is hereby deleted in its entirety and replaced with thefollowing:“[Intentionally Omitted.]” 7. This Amendment shall be governed by, interpreted under and construed in accordancewith the laws of the Commonwealth of Pennsylvania.  8. This Amendment may be executed in counterparts, each of which shall be an originaland all of which shall constitute the same document.  9. Except as modified by this Amendment, the Agreement is hereby confirmed in allrespects.*[Signature Page Follows]*
2

 
          IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the date and theyear first written above.       MYLAN LABORATORIES INC.              Name:    Title:         EXECUTIVE            
3